| First Author | Marchenko GN | Year | 2003 |
| Journal | Biochem J | Volume | 372 |
| Issue | Pt 2 | Pages | 503-15 |
| PubMed ID | 12617721 | Mgi Jnum | J:83524 |
| Mgi Id | MGI:2662353 | Doi | 10.1042/BJ20030174 |
| Citation | Marchenko GN, et al. (2003) The structure and regulation of the human and mouse matrix metalloproteinase-21 gene and protein. Biochem J 372(Pt 2):503-15 |
| abstractText | The nucleotide sequence data reported in this paper will appear in GenBank(R) Nucleotide Sequence Database under accession numbers AF520613, AY121358 and AY124569. Matrix metalloproteinases (MMPs) play key roles in tissue remodelling under normal development and, especially, in diseases ranging from malignancies to stroke. We cloned and thoroughly characterized the novel human and mouse MMP gene encoding MMP-21. MMP-21 is the last uncharacterized MMP coded by the human genome. Human and mouse MMP-21 is the orthologue of Xenopus laevis X-MMP. The latent proenzyme of MMP-21 (569 amino acid residues) consists of the prodomain, the catalytic domain and the haemopexin-like domain, and is potentially capable of being activated in its secretory pathway to the extracellular milieu by furin-like proprotein convertases. Human MMP-21 is the probable target gene of the Wnt pathway. In addition, the expression of MMP-21 is controlled uniquely by Pax and Notch transcription factors known to be critical for organogenesis. MMP-21 is expressed transiently in mouse embryogenesis and increased in embryonic neuronal tissues. Our observations clearly indicate that there is an important specific function for MMP-21 in embryogenesis, especially in neuronal cells. |
